The mark consists of the word DICERNA above the word PHARMACEUTICALS in stylized blue letters on a white background.
Mark For: DICERNA PHARMACEUTICALS™ trademark registration is intended to cover the categories of
>The color(s) blue and white is/are claimed as a feature of the mark. The mark consists of the word DICERNA above the word PHARMACEUTICALS in stylized blue letters on a white background.
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88694433 |
Mark Literal Elements | DICERNA PHARMACEUTICALS |
Mark Drawing Type | 5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | NEW APPLICATION PROCESSING 2019-11-21 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Glenn A. Gundersen |
Attorney Docket Number | 166233-040 |
2019-11-15 | Application Filed |
2019-11-21 | Location: NEW APPLICATION PROCESSING |
2019-11-21 | Status: Live/Pending |
2019-11-21 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
2019-11-22 | Transaction Date |
Party: | ![]() |
Address | 87 Cambridgepark Drive Cambridge, MASSACHUSETTS UNITED STATES 02140 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | JPEG | 2019-11-15 |
![]() | MULTI | 2019-11-15 |
![]() | MULTI | 2020-01-10 |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
IC 042. US 100 101. G & S: Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
CC0000 | The color(s) blue and white is/are claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
TEAS VOLUNTARY AMENDMENT RECEIVED | 2020-01-10 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-11-21 | |
NEW APPLICATION ENTERED IN TRAM | 2019-11-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.